首页> 美国卫生研究院文献>GE Portuguese Journal of Gastroenterology >Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score

【2h】

Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score

机译：第三代核苷类似物对慢性乙型肝炎患者的肝细胞癌：危险因素和危险评分表现

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo investigate hepatocellular carcinoma (HCC) incidence, risk factors and the performance of baseline REACH-B risk score in a Portuguese chronic hepatitis B (CHB) population on antiviral therapy.

机译：目的研究葡萄牙慢性乙型肝炎（CHB）人群接受抗病毒治疗的肝细胞癌（HCC）的发病率，危险因素和基线REACH-B危险评分的表现。

著录项

期刊名称 GE Portuguese Journal of Gastroenterology
作者
Pedro Magalhães-Costa; Luís Lebre; Paula Peixe; Sofia Santos; Cristina Chagas;
展开▼
作者单位

展开▼
年(卷),期 2016(23),5
年度 2016
页码 233–242
总页数 10
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Carcinoma Hepatocellular; Hepatitis B Chronic; Nucleotides; Risk Factors;

机译：肝细胞癌;乙型肝炎;慢性;核苷酸;风险因素;

相似文献

外文文献
中文文献
专利

1. Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score [J] . Pedro Magalh?es-Costa, Luís Lebre, Paula Peixe, GE jornal portugues de gastrenterologia. . 2016,第5期

机译：第三代Nucleos（t）ides类似物对慢性乙型肝炎患者的肝细胞癌：危险因素和危险评分表现
2. Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk [J] . Peipei Ren, Zhujun Cao, Ruidong Mo, Expert opinion on biological therapy . 2018,第7a12期

机译：基于干扰素的处理优于核核苷酸（t）IDE模拟，从而降低HBV相关的肝细胞癌，用于高风险的慢性乙型肝炎患者
3. Performance of risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients [J] . Alimentary pharmacology & therapeutics. . 2013,第2期

机译：根据2012年亚太太平洋慢性乙肝研究协会（APASL）指南，慢性乙型肝炎肝癌风险评估（REACH-B）评分对治疗资格进行分类的表现
4. Hepatocellular carcinoma, cholangiocarcinoma, colon and pancreatic carcinoma in patients with primary sclerosing cholangitis: epidemiology and risk factors [C] . U. BROOME, A. BERGQUIST Falk Liver Week . 2004

机译：肝细胞癌，胆管癌，结肠癌和初级硬化性胆管炎患者的胰腺癌：流行病学和风险因素
5. An exploratory study for the discovery of non-invasive hepatocellular carcinoma biomarkers among high-risk hepatitis C virus infected patients. [D] . Abdalla, Moemen. 2009

机译：在高危丙型肝炎病毒感染患者中发现非侵入性肝细胞癌生物标志物的探索性研究。
6. Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog [O] . Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, 2021

机译：阿司匹林减少慢性乙型肝炎接受口腔核（T）IDE模拟患者肝细胞癌的发病率
7. Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score [O] . Pedro Magalhães-Costa, Luís Lebre, Paula Peixe, 2016

机译：慢性乙型肝炎患者的肝细胞癌第三代核（t）ides类似物：风险因素和风险评分的表现

Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score

摘要

著录项

相似文献

相关主题

期刊订阅